MRI scans alone did not show how packed glioma tumors were
Original title: Apparent diffusion coefficient (ADC) as a single predictor is insufficient to predict cellular density in gliomas.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at scans and tissue from people, but it is about how scans are read, not a new treatment.
The short version
A common way of using MRI to guess how crowded tumor cells are did not match what the tissue actually showed.
What was studied. Researchers took 52 usable biopsies from 23 people with gliomas that had not been treated yet. They counted the cells in each sample under a microscope and compared that count to a measure from the person's MRI scan called ADC.
What they found. Doctors have expected that more crowded cells would show up as a lower ADC number on the scan. The results went the other way. Cell counts and ADC numbers tended to rise together, not move in opposite directions. The team also added 52 matching spots from normal looking white matter on the other side of the brain for comparison.
What this means, and what it doesn't
What it could mean: If your care team uses ADC from an MRI to guess how crowded a tumor is, that guess may be off. This study says the simple rule behind that guess does not hold up on its own. It points to a need for better ways to read scans, and for real tissue samples to check them against.
What it doesn't mean: This does not mean MRI scans are useless or that your scans were wrong. It does not change any treatment today. This was a small study at one step of research, far from everyday care. It is not a treatment and it is not a promise of a cure.
Source: PubMed, July 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.